A Study to Evaluate the Effects of Enicepatide in Participants With Obesity or Overweight, With or Without Type 2 Diabetes

NCT07670416 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

300

Enrollment

INDUSTRY

Sponsor class

Conditions

Obesity
Overweight
Type 2 Diabetes Mellitus (T2DM)

Interventions

COMBINATION_PRODUCT: Enicepatide
COMBINATION_PRODUCT: Placebo

Sponsor

Hoffmann-La Roche